Ogiwara et al. (56) showed that ARID1A-deficient cancer cells are sensitive to small molecule APR-246, which is converted to the Michael acceptor methylene quinuclidinone that reacts directly with the thiol group of GSH. This evidence concerns the gene ARID1A and cancer.